Market News

Bank of America Lowers Natural Gas Forecast Due to Mild Weather

Bank of America has reduced its natural gas price forecast, citing mild weather and changing demand patterns.

Read article

Raymond James Maintains Positive Outlook on ViaSat Amid Satellite Launch Updates

Raymond James reaffirms its favorable rating for ViaSat as the company prepares for key satellite launches.

Impact of Dressy Shoe Trend on Sportswear Stocks, Says Bernstein

Bernstein analysts discuss how the rise of dressy footwear affects sportswear stocks while growth remains steady.

ECB Needs More Data Before Policy Changes, Says Lagarde

ECB President Christine Lagarde emphasizes the need for more data before making policy decisions.

Fitch Ratings Warns of Deteriorating U.S. Credit Risk Outlook

Fitch Ratings highlights growing risks to U.S. credit from the Iran conflict and software issues.

Portugal Assures No Jet Fuel Shortages at Airports This Holiday Season

Portugal is confident that its airports will not experience jet fuel shortages despite European concerns.

Clear Street Raises Magnolia Oil & Gas Price Target Amid Rising Oil Prices

Clear Street increases Magnolia Oil & Gas price target to $35, citing higher oil prices and strong company performance.

Warsh Commits to Safeguarding Federal Reserve Independence

Kevin Warsh, nominee for Fed chair, emphasizes the importance of the central bank's independence.

Wells Fargo CEO Warns Against Premature Rate Cuts Amid Iran Conflict

Wells Fargo's CEO emphasizes caution on interest rate cuts until the Iran conflict is resolved.

Stifel Maintains Buy Rating on Tango Therapeutics Amid Positive Developments

Stifel reaffirms a Buy rating on Tango Therapeutics, highlighting potential in combination therapies.

ECB's Lagarde: Iran War's Economic Impact Less Severe Than Expected

ECB President Christine Lagarde states the economic effects of the Iran war are manageable.

Mizuho Maintains Positive Outlook on Arcus Biosciences After Trial Discontinuation

Mizuho keeps an Outperform rating on Arcus Biosciences despite a halted trial, focusing on future potential.